Geode Capital Management’s Processa Pharmaceuticals PCSA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4K | Buy |
50,573
+16,160
| +47% | +$3.31K | ﹤0.01% | 4417 |
|
|
2025
Q1 | $12.7K | Buy |
34,413
+12,431
| +57% | +$4.6K | ﹤0.01% | 4416 |
|
|
2024
Q4 | $19.6K | Buy |
21,982
+2,289
| +12% | +$2.04K | ﹤0.01% | 4386 |
|
|
2024
Q3 | $27K | Buy |
19,693
+2,456
| +14% | +$3.37K | ﹤0.01% | 4363 |
|
|
2024
Q2 | $38.8K | Buy |
+17,237
| New | +$38.8K | ﹤0.01% | 4330 |
|
|
2024
Q1 | – | Sell |
-122,033
| Closed | -$40.8K | – | 4629 |
|
|
2023
Q4 | $40.8K | Sell |
122,033
-30,637
| -20% | -$10.3K | ﹤0.01% | 4400 |
|
|
2023
Q3 | $38.9K | Buy |
152,670
+83,843
| +122% | +$21.4K | ﹤0.01% | 4479 |
|
|
2023
Q2 | $34.2K | Hold |
68,827
| – | – | ﹤0.01% | 4585 |
|
|
2023
Q1 | $36.5K | Hold |
68,827
| – | – | ﹤0.01% | 4588 |
|
|
2022
Q4 | $75K | Buy |
68,827
+3,925
| +6% | +$4.28K | ﹤0.01% | 4491 |
|
|
2022
Q3 | $146K | Hold |
64,902
| – | – | ﹤0.01% | 4375 |
|
|
2022
Q2 | $182K | Hold |
64,902
| – | – | ﹤0.01% | 4325 |
|
|
2022
Q1 | $195K | Hold |
64,902
| – | – | ﹤0.01% | 4397 |
|
|
2021
Q4 | $318K | Hold |
64,902
| – | – | ﹤0.01% | 4276 |
|
|
2021
Q3 | $556K | Buy |
64,902
+27,502
| +74% | +$236K | ﹤0.01% | 3985 |
|
|
2021
Q2 | $306K | Buy |
37,400
+9,575
| +34% | +$78.3K | ﹤0.01% | 4158 |
|
|
2021
Q1 | $303K | Buy |
+27,825
| New | +$303K | ﹤0.01% | 3987 |
|